| 名称 | Idarubicin hydrochloride |
| 描述 | Idarubicin hydrochloride (Zavedos), a hydrochloride salt form of Idarubicin, is a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells ( IC50: 3.3 ng/mL). |
| 细胞实验 | The anti-proliferative activity of the Idarubicin in the conjugate is compared to that of free drug by measuring the inhibition of [3H]thymidine uptake. Briefly, NALM-6 cells (1.5 × 106/mL) are added to a flat-bottomed microtitre plate (100 μL/well) and incubated for 1 hours at 37ºC. Free Idarubicin and Idarubicin-mAb conjugates are sterilised by filtration and diluted in sterile PBS; various concentrations are added to the wells (100 μL/well) in duplicate and the plates are incubated at 37ºC, 7% CO2 for 24 hours. Following incubation, 50 μL medium containing 1 μCi [3H]thymidine is added to each well and the plates are incubated for a further 4 hours. Cells are harvested onto glass-fibre filter-paper, dried and counted in a scintillation counter. Specificity studies are performed using the same technique where the ability of Idarubicin-anti-CD19 conjugates to kill CD19 + cells is compared to the cytotoxicity of irrelevant Idarubicin-JGT conjugates. NALM-6 cells (1.5× 106/mL, 300 μL tube) are incubated for 30 rain on ice with various concentrations of Idarubicin-anti-CD 19 or Idarubicin-JGT conjugates. Following three washes in ice-cold RPMI-1640 medium (4 mL/wash), the cells are resuspended in fresh medium and transferred to 96-well plates (100 μL/well). Each tube is set up in duplicate and two wells are plated out per tube (a total of 4 wells per drug concentration). Cells are pulsed with [3H]thymidine 24 hours later and harvested. (Only for Reference) |
| 激酶实验 | CYP450 metabolism experiments: Evaluation of Idarubicin metabolism by the CYP450 isoenzymes 3A4, 2D6, 2C8, 2C9, and 1A2 is completed using isolated human CYP450 proteins for each isoform. The high throughput P450 inhibition testing method is utilized for these evaluations. The metabolism experiments are designed to investigate the following properties of each drug: (1) if Idarubicin is a substrate of the CYP450 3A4, 2C8, 2C9, 1A2 or 2D6 isoenzymes; (2) if metabolism is affected by known inhibitors of each isoenzyme; (3) if Idarubicin is inhibitors of CYP450 isoenzymes; and (4) if caspofungin or itraconazole inhibit the CYP450 metabolism of Idarubicin. Dibenzylfluorescein (DBF) (CYP3A4, CYP2C8, CYP2C9), 3-cyano-7-ethoxycoumarin (Cyp1A2), and 7-methoxy-4-(aminomethyl)-coumarin (MAMC) (CYP2D6) are the known substrates utilized as controls to confirm the respective isoenzyme activity and evaluate the effects of Idarubicin on the isoenzyme activity. In addition, ketoconazole, quercetin, suflaphenazole, furafylline, and quinidine are utilized as control CYP450 inhibitors for 3A4, 2C8, 2C9, 1A2 or 2D6 isoenzymes, respectively. The substrate, inhibitor plus Idarubicin as indicated are added to each protein sample are incubated for 20 minutes- 60 minutes, as recommend by manufacturer, at 37oC. Reactions are stopped with an organic solvent solution and then samples are analyzed by fluorescence plate reader as appropriate. For each experiment, control samples with a known amount of substrate and synthesized metabolite, in the absence of the isoenzyme, are prepared for qualitative comparisons. All experiments are performed in triplicate. |
| 体外活性 | Idarubicin对多细胞球体展现出显著的细胞毒性活性，与其对单层细胞的抗增殖效果相当。[1] Idarubicin还能抑制CYP450 2D6的活性。[2] 与多柔比星和表柔比星相比，Idarubicin的活性分别约为57.5倍和25倍。Idarubicin能够克服P-糖蛋白介导的多药耐药性。[3] Idarubicin能够抑制中性粒细胞超氧化物自由基的形成。[4] Idarubicin可以与单克隆抗体（抗Ly-2.1、抗L3T4或抗Thy-1）耦合，同时保持蛋白质的溶解性和抗体活性。[5] Idarubicin抑制NALM-6细胞的增殖，IC50为12 nM。[6] |
| 体内活性 | Idarubicin的还原依赖于酮还原酶，并且相较于大多数酮类化合物，其还原过程具有更高的立体选择性，几乎专一性地生成(13S)-表构异构体。Idarubicin还原的高立体特异性可能源自于其羰基附近不对称中心的手性诱导效应。[7] |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : 5 mg/mL (9.36 mM), Sonication is recommended.
DMSO : 255 mg/mL (477.57 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (6.18 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
|
| 关键字 | Topoisomerase | Topo II (MCF-7 cells) | Myc | MCF-7 | leukaemias | Inhibitor | inhibit | Idarubicin Hydrochloride | Idarubicin | Fungal | DNA/RNA Synthesis | DNA synthesis | c-Myc | breast tumor | Bacterial | Autophagy | Antibiotic | 4-Demethoxydaunorubicin Hydrochloride | 4-Demethoxydaunorubicin |
| 相关产品 | Aceglutamide | Calcium Propionate | Benzyl propionate | Levulinic acid | Neomycin sulfate | BES | Terbinafine hydrochloride | Dimethyl sulfoxide | Thymidine | Sodium diacetate | Sulfamethoxazole sodium | D(+)-Raffinose pentahydrate |
| 相关库 | 抑制剂库 | 抗癌上市药物库 | 经典已知活性库 | 抗癌活性化合物库 | 抗真菌库 | 已知活性化合物库 | 临床失败化合物库 | 抗衰老化合物库 | FDA 上市药物库 | 抗病毒库 | 药物功能重定位化合物库 | 抗癌药物库 |